Paper32057366
Mesenchymal stem cell-derived extracellular vesicles alone or in conjunction with a SDKP-conjugated self-assembling peptide improve a rat model of myocardial infarction.
Firoozi S and 12 others. Biochem Biophys Res Commun, 2020. Cited by 45 papers, by iCite. Under an expression of concern.
Cite this record
ConductScience Library. Mesenchymal stem cell-derived extracellular vesicles alone or in conjunction with a SDKP-conjugated self-assembling peptide improve a rat model of myocardial infarction. Papers, record 32057366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32057366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mesenchymal stem cell-derived extracellular vesicles alone or in conjunction with a SDKP-conjugated self-assembling peptide improve a rat model of myocardial infarction.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extracellular Vesicles | Major topic |
| Mesenchymal Stem Cells | Major topic |
| Myocardial Infarction | Major topic |
| Myocytes, Cardiac | Major topic |
| Peptides | Major topic |
| Actins | |
| Animals | |
| Animals, Newborn | |
| Antigens, CD | |
| Antigens, Differentiation, Myelomonocytic | |
| Biological Transport | |
| Biomarkers | |
| Disease Models, Animal | |
| Gene Expression | |
| Humans | |
| Hydrogels | |
| Hydrogen Peroxide | |
| Injections, Intramuscular | |
| Mice | |
| Myocardium | |
| Oxidative Stress | |
| Primary Cell Culture | |
| Rats | |
| CD68 Molecule |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Expression of concern in | 42810894 | Expression of Concern to "Mesenchymal stem cell-derived extracellular vesicles alone or in conjunction with a SDKP-conjugated self-assembling peptide improve a rat model of myocardial infarction" [Biochem. Biophys. Res. Commun. 524, (2020), 903-909]. | https://conductscience.org/library/papers/42810894 |
Source PubMed
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42792732 | Small Extracellular Vesicles in Cardioprotection, Cardiac Repair, and Regeneration: Cargo Mechanisms, Producer Cell Sources, and Translational Development. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792732 | PubMed |
| 42337937 | Engineering Extracellular Vesicles for Anti-Aging Therapy: Mechanisms, Applications, and Perspectives. | Aging Cell | 2026 | https://conductscience.org/library/papers/42337937 | PubMed |
| 41879091 | Key Steps in Murine Cardiac Engineering Validation: How Does It Affect the Efficiency of Cardiac Devices? | Biomed Res Int | 2026 | https://conductscience.org/library/papers/41879091 | PubMed |
| 41291918 | The impact of natural and engineered extracellular vesicles on post-myocardial infarction angiogenesis. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/41291918 | PubMed |
| 40134775 | Crafting the future of bone regeneration: the promise of supramolecular peptide nanofiber hydrogels. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40134775 | PubMed |
| 39850481 | Extracellular vesicular microRNAs and cardiac hypertrophy. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39850481 | PubMed |
| 39769256 | The Potential of Mesenchymal Stem Cell-Derived Exosomes in Cardiac Repair. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769256 | PubMed |
| 39744211 | Cardiac cells and mesenchymal stem cells derived extracellular vesicles: a potential therapeutic strategy for myocardial infarction. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/39744211 | PubMed |
| 39603560 | Extracellular vesicle therapeutics for cardiac repair. | J Mol Cell Cardiol | 2025 | https://conductscience.org/library/papers/39603560 | PubMed |
| 39062598 | Correction: Firoozi et al. A Cell-Free SDKP-Conjugated Self-Assembling Peptide Hydrogel Sufficient for Improvement of Myocardial Infarction. Biomolecules 2020, 10, 205. | Biomolecules | 2024 | https://conductscience.org/library/papers/39062598 | PubMed |
| 38947171 | Proteomic profiling of mesenchymal stem cell-derived extracellular vesicles: Impact of isolation methods on protein cargo. | J Extracell Biol | 2024 | https://conductscience.org/library/papers/38947171 | PubMed |
| 38892376 | Evolving Strategies for Extracellular Vesicles as Future Cardiac Therapeutics: From Macro- to Nano-Applications. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892376 | PubMed |
| 38092988 | CAV1 Protein Encapsulated in Mouse BMSC-Derived Extracellular Vesicles Alleviates Myocardial Fibrosis Following Myocardial Infarction by Blocking the TGF-β1/SMAD2/c-JUN Axis. | J Cardiovasc Transl Res | 2024 | https://conductscience.org/library/papers/38092988 | PubMed |
| 37811703 | Combinatorial Effect of Biomaterials and Extracellular Vesicle Therapy for Heart Failure with Reduced Ejection Fraction: A Systematic Review of Preclinical Studies. | Adv Healthc Mater | 2023 | https://conductscience.org/library/papers/37811703 | PubMed |
| 37646039 | Research progress of extracellular vesicles and exosomes derived from mesenchymal stem cells in the treatment of oxidative stress-related diseases. | Front Immunol | 2023 | https://conductscience.org/library/papers/37646039 | PubMed |
| 37603272 | Extracellular Vesicles and Ischemic Cardiovascular Diseases. | Adv Exp Med Biol | 2023 | https://conductscience.org/library/papers/37603272 | PubMed |
| 37337466 | An Experimental and Numerical Investigation of Cardiac Tissue-Patch Interrelation. | J Biomech Eng | 2023 | https://conductscience.org/library/papers/37337466 | PubMed |
| 36902165 | Modified mRNA as a Treatment for Myocardial Infarction. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902165 | PubMed |
| 36891265 | Impact of extracellular vesicles on the pathogenesis, diagnosis, and potential therapy in cardiopulmonary disease. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36891265 | PubMed |
| 36704471 | Extracellular vesicles: Targeting the heart. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36704471 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32057366
GET https://conductscience.org/api/papers/v1/32057366/cited_by?page=2